BLACK DIAMOND THERAPEUTICS, INC. Stock Issued During Period, Value, New Issues
New shares the company issued (share-based compensation, option exercises, employee stock purchase plans, new issues, acquisitions), as filed in its 10-Q and 10-K XBRL statement of shareholders' equity. This is the dilution side; Issuer Repurchases is the other side.
- BLACK DIAMOND THERAPEUTICS, INC. stock issued during period, value, new issues for the quarter ending 2024-06-30 was $20.49M.
- BLACK DIAMOND THERAPEUTICS, INC. stock issued during period, value, new issues for the quarter ending 2024-03-31 was $4.00M.
- BLACK DIAMOND THERAPEUTICS, INC. stock issued during period, value, new issues for the quarter ending 2023-09-30 was $72.00M.
- BLACK DIAMOND THERAPEUTICS, INC. stock issued during period, value, new issues for the quarter ending 2020-03-31 was $212.10M.
- BLACK DIAMOND THERAPEUTICS, INC. stock issued during period, value, new issues for fiscal 2024 was $24.49M, a 65.98% decline from fiscal 2023.
- BLACK DIAMOND THERAPEUTICS, INC. stock issued during period, value, new issues for fiscal 2023 was $72.00M.
- BLACK DIAMOND THERAPEUTICS, INC. stock issued during period, value, new issues for fiscal 2020 was $212.10M.
| Period end | Stock Issued During Period, Value, New Issues 3 month | Stock Issued During Period, Value, New Issues 12 month |
|---|---|---|
| 2024-12-31 | $24.49M 10-K · filed 2026-03-16 | |
| 2024-06-30 | $20.49M 10-Q · filed 2025-11-06 | |
| 2024-03-31 | $4.00M 10-Q · filed 2025-11-06 | |
| 2023-12-31 | $72.00M 10-K · filed 2025-03-06 | |
| 2023-09-30 | $72.00M 10-Q · filed 2024-11-05 | |
| 2020-12-31 | $212.10M 10-K · filed 2022-03-17 | |
| 2020-03-31 | $212.10M 10-Q · filed 2021-11-08 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Cardiff Oncology, Inc. (CRDF) | United States | $0.101B | -2.22 |
| LENZ Therapeutics, Inc. (LENZ) | United States | $0.117B | -1.41 |
| COGNITION THERAPEUTICS INC (CGTX) | United States | $0.090B | -6.52 |
| enGene Therapeutics Inc. (ENGN) | $0.129B | -0.92 | |
| Pelthos Therapeutics Inc. (PTHS) | United States | $0.086B | -1.20 |
| Atara Biotherapeutics, Inc. (ATRA) | United States | $0.086B | -6.48 |
| Neumora Therapeutics, Inc. (NMRA) | United States | $0.132B | -1.48 |
| Armata Pharmaceuticals, Inc. (ARMP) | United States | $0.132B | |
| Caribou Biosciences, Inc. (CRBU) | United States | $0.134B | -1.79 |
| Vaxart, Inc. (VXRT) | United States | $0.080B | 3.84 |